As shown in Supplementary Fig. 18c–e, MDSC depletion using anti-Gr-1 antibodies could markedly abolish the antitumour activity of HSD, and the combination of HSD and the anti-Gr-1 antibody displayed a similar tumour growth as mice treated with NSD. The gene discussed is CHST3; the disease is neoplasm.